Clinical Trial Update: The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial evaluating a cross-linked hyaluronan hydrogel to reduce postsurgical peritoneal adhesions, with safety and preliminary efficacy data…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Ovarian Cysts
• Peritoneal Adhesions
• Uterine Fibroids

Drugs mentioned

• Cross-linked Hyaluronan Hydrogel (cross-linked hyaluronic acid hydrogel)

Snippet

Sponsor: BioRegen Biomedical (CHangzhou) Co., Ltd | Conditions: Myomas, Ovary Cysts | Phase 1, Phase 2 | Status: COMPLETED